Just like us, dogs and cats can experience anxiety and stress, often manifesting during events like fireworks or thunderstorms. These moments of distress underscore the importance of exploring effective, holistic ways to support our pets' well-being.
Delta-8 tetrahydrocannabinol (Delta-8 THC) is a naturally occurring cannabinoid that has gained popularity for its psychoactive and potential therapeutic effects. Studies have shown that Delta-8 THC can help reduce anxiety and depression symptoms while possessing the potential to supplement in addiction and dependency recovery, specifically those related to alcohol and nicotine.
The recent cannabis laws in North Carolina have created a positive atmosphere for cannabis availability throughout the state. As of November 2020, the state has decriminalized simple possession of marijuana, allowed for medical marijuana use, and made hemp production legal.
The future of cannabinoids and their integration into pharmaceuticals is a topic that has been the subject of much speculation and debate. While the use of cannabinoids as a therapeutic agent has been around for centuries, the recent explosion of research into the potential therapeutic applications of cannabinoids has resulted in a flurry of activity in the pharmaceutical industry.
On October 14, 2020, the Drug Enforcement Administration (DEA) issued a final ruling that makes the synthetic form of cannabis known as THC-O illegal. The ruling, which was issued in response to a petition filed by the state of Arizona, declares that THC-O (Tetrahydrocannabinol O-acetate) is a Schedule I drug under the Controlled Substances Act (CSA).
The legality of THCA flower in the United States has been a hot topic of discussion as of late, as the popularity of THC-rich cannabis products continues to rise. THCA (tetrahydrocannabinolic acid) is the non-psychoactive precursor to THC (tetrahydrocannabinol), the main psychoactive component in cannabis
Discovered over sixty years ago, Cannabichromene (CBC) is one of the most prevalent cannabinoids in the cannabis plant, yet virtually unknown to many people. CBC is not a scheduled drug and considered non-psychoactive because it does not cause a euphoric response when consumed.
The Pink Elephant Cannabinoid Education Initiative was started by concerned industry members. The Cannabis Consumer is now in the mix of the Wild Wild West of product development, with very little regulation and oversight. We all can agree too much oversight is bad, but a little more oversight in an ingestible market isn't a bad idea!